Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV.
作者信息
Vannappagari Vani, McCallister Scott, Romach Beth, Bush Mark, Stanislaus Dinesh, Root Charlotte, Lampkin Christine, Nwokolo Nneka, Puga Ana, Moreira Sebastian, Salem Farzaneh, DeMasi Ralph, Payvandi Nassrin, Smith Kimberly, Garges Harmony, de Ruiter Annemiek
机构信息
ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC, 27701, USA.
VP, Global Head of Epidemiology & Real World Evidence, ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC, 27701, USA.
出版信息
Infect Dis Ther. 2024 Jul;13(7):1391-1398. doi: 10.1007/s40121-024-00993-4. Epub 2024 May 22.
Abstract
摘要
相似文献
1
Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV.响应行动呼吁：加速为感染艾滋病毒的孕妇抗逆转录病毒治疗生成临床数据的框架
Infect Dis Ther. 2024 Jul;13(7):1391-1398. doi: 10.1007/s40121-024-00993-4. Epub 2024 May 22.
2
Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.抗逆转录病毒初治和经治的 HIV 感染孕妇在高效抗逆转录病毒治疗下达到病毒载量抑制的时间：对妊娠晚期就诊孕妇的影响。
BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.
3
Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.比较两种服务提供模式在从单剂量奈韦拉平向多药物抗逆转录病毒方案过渡期间预防母婴传播艾滋病毒（PMTCT）的效果。
BMC Public Health. 2010 Dec 6;10:753. doi: 10.1186/1471-2458-10-753.
4
Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.赞比亚预防艾滋病母婴传播：在初级卫生保健中心实施有效的抗逆转录病毒疗法方案
BMC Public Health. 2009 Aug 27;9:314. doi: 10.1186/1471-2458-9-314.
5
The next generation of the World Health Organization's global antiretroviral guidance.下一代世界卫生组织全球抗逆转录病毒指南。
J Int AIDS Soc. 2013 Jun 30;16(1):18757. doi: 10.7448/IAS.16.1.18757.
6
Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens.提高抗逆转录病毒毒性的小鼠妊娠模型的临床相关性；当前 HIV 抗逆转录病毒方案的药代动力学剂量优化研究。
Antiviral Res. 2018 Nov;159:45-54. doi: 10.1016/j.antiviral.2018.09.008. Epub 2018 Sep 17.
7
Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.根据抗逆转录病毒预防方案（妊娠和哺乳期的三联抗逆转录病毒预防与齐多夫定/单剂量奈韦拉平预防），产后 18-24 个月时母婴 HIV-1 疾病进展：Kesho Bora 随机对照试验。
Clin Infect Dis. 2012 Aug;55(3):449-60. doi: 10.1093/cid/cis461. Epub 2012 May 9.
8
An assessment of antiretroviral drug initiation to pregnant women of unknown HIV status during labour and delivery in Cameroon.喀麦隆分娩时对HIV感染状况不明的孕妇启动抗逆转录病毒药物治疗的评估。
Afr J AIDS Res. 2018 Sep;17(3):265-271. doi: 10.2989/16085906.2018.1515780. Epub 2018 Oct 14.
9
Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007.艾滋病感染孕妇在医疗补助计划中抗逆转录病毒药物使用的趋势：2000-2007 年。
AIDS Patient Care STDS. 2014 Feb;28(2):56-65. doi: 10.1089/apc.2013.0165.
10
Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.布基纳法索预防母婴HIV-1传播：通过聚合酶链反应评估垂直传播、亚型的分子特征分析及抗逆转录病毒药物耐药性测定
Glob Health Action. 2015 Jan 27;8:26065. doi: 10.3402/gha.v8.26065. eCollection 2015.
引用本文的文献
1
Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review.多替拉韦/拉米夫定在HIV-1感染孕妇管理中的作用：一项叙述性综述
Infect Dis Ther. 2025 Jan;14(1):59-80. doi: 10.1007/s40121-024-01085-z. Epub 2024 Dec 9.
本文引用的文献
1
Science-Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical Labels.基于科学的方法来协调临床试验和药品标签中的避孕建议。
Clin Pharmacol Ther. 2023 Feb;113(2):226-245. doi: 10.1002/cpt.2602. Epub 2022 May 5.
2
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.患有人类免疫缺陷病毒的孕妇和哺乳期妇女进行前瞻性研究的重要性。
Clin Infect Dis. 2019 Sep 13;69(7):1254-1258. doi: 10.1093/cid/ciz121.
3
Improving postpartum retention in care for women living with HIV in the United States.提高美国 HIV 感染者产妇产后护理的保持率。
AIDS. 2018 Jan 14;32(2):133-142. doi: 10.1097/QAD.0000000000001707.
4
Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets.基于社区的干预措施，以改善和维持抗逆转录病毒治疗的依从性、在低收入和中等收入国家的艾滋病毒护理中的留存率以及临床结局，以实现联合国艾滋病规划署的90-90-90目标
Curr HIV/AIDS Rep. 2016 Oct;13(5):241-55. doi: 10.1007/s11904-016-0325-9.
5
Decentralising HIV treatment in lower- and middle-income countries.在低收入和中等收入国家分散艾滋病病毒治疗工作。
Cochrane Database Syst Rev. 2013 Jun 27;2013(6):CD009987. doi: 10.1002/14651858.CD009987.pub2.
6
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.妊娠抗逆转录病毒治疗的药代动力学优化。
Clin Pharmacokinet. 2012 Oct 1;51(10):639-59. doi: 10.1007/s40262-012-0002-0.
7
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy.孕期使用奈韦拉平作为联合抗逆转录病毒治疗的一部分导致的母体肝毒性。
HIV Med. 2006 May;7(4):255-60. doi: 10.1111/j.1468-1293.2006.00369.x.
Zotero 插件